NSE filing, NSE: MARICO. Summary written from the filing by ALFA Finder's alert engine.
Marico Ltd: key numbers
- Share price
- ₹769.65
- Market cap
- ₹1,00,070 Cr
- Revenue (annual)
- ₹13,611 Cr
- Net profit (annual)
- ₹1,762 Cr
- P/E (TTM)
- 53.0×Sector 38.3×
- Promoter holding
- 58.83%-0.08% QoQ
- FII holding
- 22.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Marico Ltd
All →Marico Business Update
Marico announced 89.3% reduction in Scope 1 and 2 GHG emissions intensity since FY13. It also reported 29.95% Scope 3 reduction and 77.3% renewable energy usage.
Marico Other Announcement
Marico Ltd submitted its shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulatory filing requirements.
Marico Board Meeting Date
Marico Limited will hold a board meeting on November 2, 2026. The board will consider and approve un-audited financial results for the quarter ended September 30, 2026.
Marico Acquisition Worth ₹1,012 Cr
Marico Limited acquired a 24.09% stake in Satiya Nutraceuticals (PLIX brand) for ₹1,012.03 Crores, increasing its total ownership to 84.09%.
- Value
- ₹1,012 Cr
Marico Business Update
Marico released its quarterly operational update for Q2 FY 2026-27, highlighting volume growth trends and business resilience across its domestic and international portfolios.
Marico Management Change
Mr. Rajeev Vasudeva will retire as an Independent Director of Marico Limited effective October 31, 2026. Mr. Bhaskar Bhat will succeed him as Chairman of the NRC.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.